Loading…
Access to Pediatric Technologies Act of 2025
Legislative Progress
Introduced
January 24, 2025
Latest Action
January 24, 2025
Primary Sponsor
Marsha BlackburnRepublican(TN)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
Access to Pediatric Technologies Act of 2025 This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish, upon request, specific payment methodologies for qualifying pediatric technologies under the Medicare physician fee schedule. Qualifying pediatric technologies are medical devices that are (1) covered under Medicare, (2) approved by the Food and Drug Administration, (3) currently billed using a specified temporary billing code for emerging technologies, and (4) predominantly used or specifically designated for pediatric patients. The CMS must develop a payment methodology for a qualifying pediatric technology upon request from the manufacturer and based on available data, including pricing information and claims data. Manufacturers must include relevant information in their requests to enable the CMS to develop the corresponding methodologies.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2025 · fourth_quarter · Medicare/Medicaid
Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. Issues related to Most Favored Nation drug pricing.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2025 · fourth_quarter · Medicare/Medicaid
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Client expense: $340,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Medicare/Medicaid
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Client expense: $350,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Medicare/Medicaid
Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to Medicaid. Issues related to Most Favored Nation drug pricing.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2025 · third_quarter · Natural Resources
Issues relating to the staffing shortages at the Bureau of Reclamation and the Western Area Power Administration Issues relating to the Central Valley Project H.R. 2492/S.249, the Fire Safe Electrical Corridors Act H.R. 8790/S.1462, the Fix Our Forests Act Issues related to wildfire
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Medicare/Medicaid
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Medicare/Medicaid
Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. Monitored H.R.1, One Big Beautiful Bill Act, as it relates to Medicaid. Issues related to Most Favored Nation drug pricing.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2025 · second_quarter · Natural Resources
Issues relating to the staffing shortages at the Bureau of Reclamation and the Western Area Power Administration Issues relating to the Central Valley Project H.R. 2492/S.249, the Fire Safe Electrical Corridors Act H.R. 8790/S.1462, the Fix Our Forests Act Issues related to wildfire
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Medicare/Medicaid
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Client expense: $430,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Medicare/Medicaid
Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE